Services

Clinical Phase API - Overview

Pharma Solutions has been providing Clinical API services for over 30 years to a global client base. The Group has a number of process development labs, kilo labs and pilot plants across a network of sites in North America, UK and India. The Group works with a number of biotech/virtual pharma companies to supply API from preclinical/Phase I studies to commercial launch including Clinical API and is uniquely positioned to integrate services across geographies to give customers greater reliability, cost competitiveness and speed.

• Our Torcan (Toronto) site in North America and Morpeth sites in UK specialize in synthesis of APIs at Kilogram scale for early evaluations and are also supported by full range of material characterization studies
• Our Chennai site has been recently expanded for scale up equipment and is a key site for advanced intermediates and API synthesis
• Our Grangemouth site in UK is engaged in supply of cytotoxic APIs with special focus on supply of early phase Monoclonal Antibodies and cytotoxic API conjugates